Differences in glucose concentration shows new perspectives in gastric cancer metabolism

Emerson Lucena da Silva1, Felipe Pantoja Mesquita1, Adrhyann Jullyanne de Sousa Portilho1

  • 1Laboratory of Pharmacogenetics, Drug Research and Development Center (NPDM), Federal University of Ceará, Cel. Nunes de Melo, 1000 - Rodolfo Teófilo, Fortaleza, Brazil.

Insights

This study investigated how glucose levels affect gastric cancer cells in lab cultures. Researchers recommend using low glucose media for more accurate metabolic studies in gastric cancer research.

Area of Science:

  • Oncology
  • Metabolic Research
  • Cell Biology

Background:

  • Gastric cancer (GC) remains a leading cause of cancer mortality globally.
  • Existing therapies are insufficient, necessitating novel treatment strategies.
  • In vitro metabolic studies in GC are complicated by variable glucose concentrations in culture media.

Purpose of the Study:

  • To assess the impact of varying glucose concentrations (high, low, free) on gastric cancer cell viability, glucose uptake, and LDH activity.
  • To investigate how glucose levels influence cellular phenotype and gene expression, particularly EMT and metabolism-related genes, in metastatic GC cells.
  • To determine optimal glucose concentrations for in vitro metabolic studies in GC.

Main Methods:

  • Gastric cancer cell lines were cultured in media with high (25mM), low (5.5mM), or free (0mM) glucose.
  • Cellular viability, glucose uptake, and lactate dehydrogenase (LDH) activity were measured.
  • Phenotypic assays and gene expression profiling (mRNA levels) were performed, focusing on EMT, metabolism, and cancer development markers.

Main Results:

  • Metastatic GC cells showed significant alterations in free glucose medium compared to other conditions.
  • Phenotypic assays revealed minimal differences between high and low glucose media.
  • Gene expression analysis indicated distinct mRNA levels of metabolism-related genes in low glucose versus high glucose conditions.

Conclusions:

  • Low glucose medium (5.5mM) is recommended for in vitro metabolic studies of gastric cancer due to its closer approximation to physiological glucose levels.
  • Metabolic reprogramming in gastric cancer presents potential therapeutic targets.
  • These findings may offer alternative therapeutic strategies for metastatic gastric cancer patients.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
2.0K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
362
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
2.6K
Glucose Absorption Into the Small Intestine01:26

Glucose Absorption Into the Small Intestine

Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
32.6K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
4.2K